EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 163 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2023. The put-call ratio across all filers is 2.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $265,761 | -83.4% | 36,158 | -73.4% | 0.00% | -88.9% |
| Q4 2022 | $1,604,849 | +71.3% | 135,889 | +204.5% | 0.01% | +50.0% |
| Q3 2022 | $937,000 | +33.9% | 44,628 | +98.0% | 0.01% | +20.0% |
| Q2 2022 | $700,000 | -22.7% | 22,539 | +2.1% | 0.01% | -37.5% |
| Q1 2022 | $906,000 | +26.0% | 22,065 | +53.7% | 0.01% | -11.1% |
| Q3 2021 | $719,000 | +18.1% | 14,355 | +48.5% | 0.01% | +28.6% |
| Q2 2021 | $609,000 | -68.2% | 9,666 | -47.8% | 0.01% | -74.1% |
| Q3 2020 | $1,915,000 | – | 18,530 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zebra Capital Management LLC | 22,111 | $908,000 | 2.08% |
| Global Alpha Capital Management Ltd. | 460,530 | $18,909,000 | 1.62% |
| AIMZ Investment Advisors, LLC | 70,625 | $2,900,000 | 1.19% |
| Bridge City Capital, LLC | 39,835 | $1,636,000 | 0.76% |
| PALISADE CAPITAL MANAGEMENT, LP | 560,409 | $23,010,000 | 0.53% |
| EARNEST PARTNERS LLC | 2,071,376 | $85,051,000 | 0.50% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,721 | $12,430,000 | 0.50% |
| SummerHaven Investment Management, LLC | 14,476 | $594,000 | 0.34% |
| Ridgewood Investments LLC | 10,004 | $411,000 | 0.27% |
| AtonRa Partners | 11,505 | $472,000 | 0.26% |